QualityStocksNewsBreaks Archives

FridayApr 24, 2026 3:39 pm

QualityStocksNewsBreaks – Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Positions Across Key North American Rare Earth Projects

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company focused on rare earth projects across North America, is positioning itself as the rare earth elements (“REE”) market has moved from a niche segment of the mining industry to a strategic focal point for governments and investors. “Powermax’s approach reflects a portfolio model rather than a single-asset bet,” reads a recent article. “The company holds interests in several REE exploration projects across North America, including the Atikokan project in Ontario, the Cameron project in British Columbia, and…

FridayApr 24, 2026 3:17 pm

QualityStocksNewsBreaks – Rail Vision Ltd. (NASDAQ: RVSN) Integrating AI and Imaging to Redefine Train Safety Systems

Rail Vision (NASDAQ: RVSN) is poised for opportunity as the global train collision avoidance market is undergoing a dramatic transformation, driven by the convergence of advanced camera systems and artificial intelligence. The company is “developing proprietary AI-integrated sensing platforms designed to detect hazards in real time and ultimately enable fully autonomous train operations,” reads a recent article. “Israel-based Rail Vision has built its technology around the idea that the most dangerous moments for a train are the ones no one planned for. The company’s offerings have been described as AI-powered perception systems that allow rail operators to predict and prevent collisions, operating…

FridayApr 24, 2026 2:52 pm

QualityStocksNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Unlocking New Potential in Precision Cancer Treatment

LIXTE Biotechnology Holdings (NASDAQ: LIXT) is advancing the precision oncology landscape, developing therapies that complement existing cancer treatments while integrating cutting-edge data solutions. “The company’s lead program, LB-100, is a novel small-molecule compound designed to enhance the efficacy of chemotherapy and radiation, aiming to improve patient outcomes while reducing treatment-related side effects,” reads a recent article. “By focusing on improving the therapeutic index of existing cancer modalities, the company is tackling a recurrent challenge in the field of oncology: maximizing treatment impact while cutting down risks to healthy tissue.” To view the full article, visit https://ibn.fm/EE6ya About LIXTE Biotechnology Holdings Inc. LIXTE…

FridayApr 24, 2026 2:22 pm

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Advances Toward Commercial Deployment of AI Solution

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF) was featured in a recent article that discussed its move toward commercial deployment of its voice-based artificial intelligence platform for detecting drug and alcohol impairment, with a focus on industrial safety applications in South America’s mining sector. The publication reads, “The biotechnology company recently appointed Chilean policy specialist Felipe Leyton to lead commercialization efforts in the region, a move that signals MindBio’s transition from technology development to field implementation in large enterprise environments… Leyton brings experience in national drug policy and…

FridayApr 24, 2026 2:00 pm

QualityStocksNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Launches Sports.com Predict Platform

SEGG Media (NASDAQ: SEGG, LTRYW) announced the launch of Sports.com Predict, marking its entry into the fast-growing prediction markets sector through its subsidiary Sports Predicts Limited. The platform, currently in development and expected to launch in summer 2026, will integrate prediction functionality into the Sports.com ecosystem, enabling the company to convert fan engagement into transactional activity and generate recurring, high-margin revenue through user-driven transaction fees. Building on recent acquisitions including Veloce Media Group and Quadrant, SEGG Media said the initiative leverages its large audience base to support scalable growth as global prediction market volumes continue to expand. To view the…

FridayApr 24, 2026 1:52 pm

QualityStocksNewsBreaks – Earth Science Tech Inc. (ETST) Aligns with Next Phase of Telehealth Through Integrated Platform

Earth Science Tech (OTC: ETST) is positioned for opportunity as telehealth evolves from simple video visits into a comprehensive care model. “The company describes itself as a strategic holding company that acquires and actively manages operating businesses in pharmaceuticals, telemedicine, healthcare services, real estate, and selected consumer markets. ETST’s healthcare-related holdings include telemedicine and pharmaceutical operations designed to support a more connected platform approach; in addition, its compounding operations through RxCompoundStore.com and Mister Meds directly align with the expanding digital healthcare segment,” reads a recent article. “Earth Science Tech recently reported that its operations include compounding pharmaceuticals, telemedicine, and real estate…

FridayApr 24, 2026 11:49 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Deploys ADIO(R) Platform at NFL Draft, Advances NILX Launch

Datavault AI (NASDAQ: DVLT) announced the live deployment of its ADIO(R) athlete engagement platform at the NFL Draft, delivering real-world validation of the technology in a high-profile, high-demand environment through its partnership with the NFL Alumni Health initiative. The company said the activation is generating strong engagement among draftees, alumni and league stakeholders, reinforcing the platform’s scalability and commercial viability, while supporting its push toward the launch of DataVault NILX, a name, image and likeness monetization platform targeting a rapidly growing multi-billion-dollar market opportunity across collegiate NIL and global sports sponsorship. To view the full press release, visit https://ibn.fm/nnuw0 About Datavault AI Inc. Datavault AI (Nasdaq: DVLT) is…

FridayApr 24, 2026 11:25 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Launches Live Robot Pilot at IOA Championship

Nightfood Holdings (OTCQB: NGTF) announced the launch of a live pilot deployment of its autonomous robots, BIM-E and TIM-E, at the IOA Championship presented by Morongo Casino Resort and Spa, taking place April 24–26, 2026, at Morongo Golf Club at Tukwet Canyon in California. The deployment marks a key step in the company’s commercialization strategy, with the robots providing beverage service, waste management and delivery in a high-traffic event setting, while demonstrating scalability across outdoor hospitality environments. Following the event, the systems are expected to remain onsite for ongoing clubhouse operations, supporting continued validation as Nightfood advances production and scaling efforts in collaboration with Foxconn and NUWA Robotics. To view the full…

FridayApr 24, 2026 11:02 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in NetworkNewsAudio Editorial on Pipeline-Driven Valuation

Oncotelic Therapeutics (OTCQB: OTLC) is featured in a NetworkNewsAudio Audio Press Release titled “When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech,” which highlights how late-stage drug development assets increasingly drive valuation in the biopharma sector. The editorial, supported by analysis from McKinsey & Company, notes that companies tend to realize the majority of value creation as products approach commercialization, reflecting reduced risk and clearer revenue visibility, a trend directly relevant to Oncotelic’s oncology-focused pipeline and strategic development approach. To view the full press release, visit https://ibn.fm/u5BVm About Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of oncology and immunotherapy…

FridayApr 24, 2026 10:48 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Highlights Partnership Strategy to Advance Pipeline

Oncotelic Therapeutics (OTCQB: OTLC) provided a corporate update emphasizing its partnership-driven strategy to advance its oncology and rare disease pipeline and enhance shareholder value. The company cited its joint venture with GMP Biotechnology, which contributed to a $249.0 million increase in its balance sheet based on an independent third-party valuation, and said it is pursuing additional collaborations to support development and commercialization efforts. Management noted the approach is designed to advance multiple drug candidates in parallel while maintaining capital efficiency and unlocking the value of its intellectual property portfolio. To view the full press release, visit https://ibn.fm/Ps3PO About Oncotelic Therapeutics, Inc. Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the…

Site Search

Company Search

Category: QualityStocksNewsBreaks